RELAnivolumabNIVOrelatlimabipilimumabbasal cell carcinoma
… be enrolled in the first stage. If ≥2 patients respond to NIVO+RELA, the study will continue enrollment for a total of 20 patients.…
1articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: RELA ×
RELA
This drug is selected. Its supporting articles are shown below.